Article published by : Max Health on Sunday, September 23, 2012

Category : Blood Cancer

Essential Things That You Need To Know About Chronic Myelogenous Leukemia

Chronic myelogenous leukemia is a sinister blood cancer which can be called by several other names.

The distinctions between chronic and acute forms of this and other illnesses are often associated with the rapidity of the onset of the disease; the onset of acute myelogenous leukemia occurs quickly and dramatically, whereas chronic myelogenous leukemia may take years to develop.

Myelogenous leukemia symptoms include: Bleeding and bruising quite easily, feelings of fatigue or usually run-down, fever in the absence of other symptoms, persistent infections, loss of appetite, unforeseen weight loss, distress below the ribs on the left side, pale skin, and night sweats. These same signals might be chronic myelogenous leukemia symptoms. In the event that these symptoms show themselves, you ought to consult with your family doctor as quickly as possible. Successful treatment of cancer depends in large part upon early diagnosis.

Treatments for myelogenous leukemia are diverse and will be picked by you and your doctor based on a number of variables like your age, your overall health, and the stage of your disease. Recently, drugs have been developed which attack the protein produced by the BCR-ABL gene - tyrosine kinase - preventing the significant increase of abnormal cells from continuing. These drugs include: Imatinib (Gleevec,) Dasatinib (Sprycel,) as well as Nilotinib (Tasigna.) Other feasible treatments for these cancers include chemotherapy and stem cell transplantation.

Ruthless research on leukemia in general and these types of leukemia notably goes on each day. This enhances the survival rates drastically. For every year the patient remains in remission, the more likely it is that he or she will be able to benefit from the results of the clinical trials and research which are ongoing. Obviously, every cancer patient would like to know exactly how long he has to live.

The way in which cancer survival rates are established is deceptive. When your doctor tells you about a five-year survival rate, it is simply an answer to this question: What percentage of the patients is alive after five years? Provided the capricious nature of cancer, which fades away from one place in the body only to reappear in another years afterwards, it is impossible for anyone to really know how long a cancer patient has to live any more than it will be possible for a healthy person to know he won't be struck by an oncoming train before the day is over. Discussions with cancer patients reveal that their strategy is often one of moving forward one day at a time - hoping for the best but preparing for the worst.

All of those things said, there are publicized survival rates for every kind of cancer. The chronic myelogenous leukemia survival rate is 90% as set up by the scientific community. This implies at the end of five years 90% of the patients are still living.

The severe myelogenous leukemia survival rate seems to be less hopeful at first glance since, at the end of five years, only 40% of the patients remain alive. It should be remembered here that this disease usually strikes older people who may already be frail or else not able to fend off the infections and immune issues related to the disease. Since they are older, they may also fall prey to other conditions unrelated to the leukemia - strokes, cardiovascular disease and other such ailments. The acute myelogenous leukemia prognosis shows improvements every year as does the myelogenous leukemia prognosis because of ongoing research.


By: Max Health

Free Article Directory:

Copy and Paste Link Code:

Article ID 1003080
This article has been viewed 646 times